Sign in
4

Changes in Ownership

SpyGlass Pharma, Inc. Filed Acc 0002106895-26-000004

Options or other derivatives

  • Chief Operating Officer acquired 105,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Dennewill James Robert Jr. Chief Operating Officer 2026-02-05 Grant or award · Stock Option (right to buy) +105,000 105,000 D
Loading xslF345X05/form4-02092026_090235.xml…